Solara Active Pharma Sciences Limited (SOLARA) — Board Meeting | 18 August 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Allotment of 2,250 equity shares under ESOP 2018 approved by board.
🔄 What Changed
Paid-up capital rose to Rs 48.06 crores from Rs 47.79 crores.
💡 Investor Takeaway
This small ESOP issuance slightly dilutes shares but shows continued employee incentive alignment.

Solara Active Pharma Sciences approved the allotment of 2,250 equity shares under its Employee Stock Option Plan 2018, increasing paid-up capital to Rs 48.06 crores from Rs 47.79 crores. The shares were fully paid at Rs 10 each, with exercise price Rs 375 and premium Rs 365 per share. This dilutes existing shareholders but reflects employee incentive utilization.

📄 View Original Announcement (PDF)

About Solara Active Pharma Sciences Limited (SOLARA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹3,425.95 Cr ROE: -0.1% ROCE: 4.7%

View full SOLARA stock details →

📡 Get AI alerts when SOLARA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SOLARA — Free

📊 More SOLARA filings

See all SOLARA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SOLARA files new disclosures

Track SOLARA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SOLARA — Free

Free account · 2 AI queries/day